StockData
Puma Biotechnology, Inc. logo

Puma Biotechnology, Inc. (PBYI) stock

PBYINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 14/3019% below fair value
$7.22+0.08 (+1.12%)

Close on Nov 18, 2026Market cap $372.70MP/E 13.9Yield –

Puma Biotechnology enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Puma Biotechnology's enterprise value was $326.11M on Nov 11, 2026, against $199.73M a year earlier. Over the last 5 years it ranged from $121.42M to $446.71M, with a median of $205.83M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$326.11M+33.1%
2025Dec 31, 2025$245.08M+77.8%
2024Dec 31, 2024$137.82M-46.3%
2023Dec 29, 2023$256.89M+4.9%
2022Dec 30, 2022$244.78M+61.9%
2021Dec 31, 2021$151.18M-61.8%
2020Dec 31, 2020$395.94M+71.9%
2019Dec 31, 2019$230.32M-64.5%
2018Dec 31, 2018$647.90M-81.9%
2017Dec 29, 2017$3.59B+303.8%
2016Dec 30, 2016$888.91M-61.3%
2015Dec 31, 2015$2.29B-58.6%
2014Dec 31, 2014$5.55B+93.0%
2013Dec 31, 2013$2.87B+739.5%
2012Dec 31, 2012$342.40M–

More Puma Biotechnology figures

See a number that looks wrong?